Ameritas Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.31M Sell
12,441
-9,874
-44% -$1.83M 0.12% 170
2025
Q1
$4.27M Sell
22,315
-1,621
-7% -$310K 0.17% 130
2024
Q4
$4.25M Buy
23,936
+3,657
+18% +$650K 0.15% 135
2024
Q3
$4M Sell
20,279
-3,979
-16% -$786K 0.17% 129
2024
Q2
$4.16M Sell
24,258
-2,013
-8% -$345K 0.16% 132
2024
Q1
$4.49M Buy
26,271
+7,280
+38% +$1.25M 0.19% 105
2023
Q4
$3.15M Sell
18,991
-8,626
-31% -$1.43M 0.17% 118
2023
Q3
$4.12M Buy
27,617
+16,362
+145% +$2.44M 0.21% 99
2023
Q2
$1.53M Sell
11,255
-13,614
-55% -$1.84M 0.2% 120
2023
Q1
$4.03M Sell
24,869
-7,557
-23% -$1.22M 0.2% 98
2022
Q4
$5.24M Buy
32,426
+3,550
+12% +$574K 0.24% 97
2022
Q3
$3.88M Buy
28,876
+86
+0.3% +$11.5K 0.23% 93
2022
Q2
$4.41M Buy
28,790
+2,490
+9% +$381K 0.26% 84
2022
Q1
$4.26M Buy
26,300
+1,215
+5% +$197K 0.16% 99
2021
Q4
$3.4M Buy
+25,085
New +$3.4M 0.12% 142